DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Stocks To Watch Today: Aurobindo Pharma, Vimta Labs, Natco Pharma, Power Grid, Apollo Micro System & More

NDTV Profit 6d ago·24 Aug 2026, 1:30 am

Vimta Labs is likely to be in focus today as investors react to recent corporate developments. The company is a key player in the contract research and manufacturing space, serving the pharmaceutical and biotechnology sectors.

This attention is driven by expectations of positive news or a significant update regarding its business operations. For investors, the stock's movement will depend on the specific nature of the announcement and how it aligns with the company's growth trajectory.

Traders should monitor the volume and price action to gauge market sentiment. Keeping an eye on any official statements from the company will provide further clarity on the reasons behind the current focus.